| Urinary tract infection
Zerbaxa vs Targadox
Side-by-side clinical, coverage, and cost comparison for urinary tract infection.Deep comparison between: Zerbaxa vs Targadox with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsTargadox has a higher rate of injection site reactions vs Zerbaxa based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Targadox but not Zerbaxa, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Zerbaxa
Targadox
At A Glance
IV infusion
Every 8 hours
Cephalosporin/beta-lactamase inhibitor
Oral
Daily to twice daily
Tetracycline antibiotic
Indications
- Peritonitis
- Urinary tract infection
- Pyelonephritis
- Hospital acquired pneumonia
- VABP
- Rocky Mountain Spotted Fever
- TYPHUS
- Q Fever
- Rickettsialpox
- Respiratory Tract Infections
- Respiratory Tract Infections
- Upper Respiratory Infections
- Urinary tract infection
- Lymphogranuloma Venereum
- Psittacosis
- Trachoma
- Inclusion conjunctivitis
- Urethritis
- Uterine Cervicitis
- Proctitis
- non-gonococcal urethritis (NGU)
- Relapsing Fever
- Chancroid
- Plague
- Tularemia
- Cholera
- Campylobacter infection
- Brucellosis
- Bartonella Infections
- Granuloma Inguinale
- Anthrax disease
- Gonorrhea
- Syphilis
- Yaws
- Listeriosis
- Necrotizing Ulcerative Gingivitis
- Actinomycosis
- Clostridium Infections
- Amebiasis
- Acne Vulgaris
- Malaria
Dosing
Peritonitis 1.5 g IV every 8 hours over 1 hour for 4 to 14 days, used in conjunction with metronidazole 500 mg IV every 8 hours; pediatric patients: 30 mg/kg up to 1.5 g every 8 hours for 5 to 14 days.
Urinary tract infection, Pyelonephritis 1.5 g IV every 8 hours over 1 hour for 7 days; pediatric patients: 30 mg/kg up to 1.5 g every 8 hours for 7 to 14 days.
Hospital acquired pneumonia, VABP 3 g IV every 8 hours over 1 hour for 8 to 14 days in adult patients 18 years and older.
Adults (general infections) 200 mg on day 1 (100 mg every 12 hours), then 100 mg/day maintenance; 100 mg every 12 hours for severe or chronic Urinary tract infection.
Pediatric patients <45 kg (severe infections) 2.2 mg/kg every 12 hours; for less severe disease (>8 years, <45 kg): 4.4 mg/kg divided into two doses on day 1, then 2.2 mg/kg/day as a single or divided dose. Children >=45 kg receive the adult dose.
Gonorrhea 100 mg twice daily for 7 days; alternate single-visit dose: 300 mg followed by 300 mg 1 hour later, may be taken with food or beverage.
Urethritis, Uterine Cervicitis, Proctitis, non-gonococcal urethritis (NGU) 100 mg twice daily for 7 days.
Syphilis (early, penicillin-allergic patients) 100 mg twice daily for 2 weeks.
Syphilis (>1 year duration, penicillin-allergic patients) 100 mg twice daily for 4 weeks.
Malaria (prophylaxis) Adults: 100 mg once daily beginning 1-2 days before travel, continuing during travel, and for 4 weeks after leaving the malarious area. Pediatric patients >8 years: 2 mg/kg once daily up to the adult dose.
Anthrax disease (inhalational, post-exposure) Adults: 100 mg twice daily for 60 days. Children <45 kg: 2.2 mg/kg twice daily for 60 days; children >=45 kg receive the adult dose.
Contraindications
- Known serious hypersensitivity to components of ZERBAXA (ceftolozane and tazobactam), piperacillin/tazobactam, or other members of the beta-lactam class
- Hypersensitivity to any of the tetracyclines
Adverse Reactions
Most common (>=5%) Nausea, diarrhea, headache, pyrexia
Serious Hypersensitivity reactions, Clostridioides difficile-associated diarrhea, intracranial hemorrhage, renal impairment/renal failure, hepatic transaminase increased
Most common Nausea, vomiting, diarrhea, anorexia, glossitis, dysphagia, enterocolitis, maculopapular and erythematous rashes.
Serious Toxic epidermal necrolysis, Stevens-Johnson syndrome, anaphylaxis, anaphylactoid purpura, DRESS, intracranial hypertension, hemolytic anemia, thrombocytopenia, hepatotoxicity, esophagitis, esophageal ulceration, permanent tooth discoloration.
Pharmacology
Ceftolozane is a cephalosporin antibacterial that inhibits bacterial cell wall biosynthesis by binding to penicillin-binding proteins (PBPs); tazobactam is an irreversible beta-lactamase inhibitor that extends ceftolozane activity against beta-lactamase-producing organisms.
Tetracycline-class antibacterial; doxycycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, exhibiting bacteriostatic activity against a broad range of Gram-positive and Gram-negative bacteria.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Zerbaxa
- Covered on 5 commercial plans
- PA (6/12) · Step Therapy (6/12) · Qty limit (0/12)
Targadox
- Covered on 5 commercial plans
- PA (5/12) · Step Therapy (9/12) · Qty limit (10/12)
UnitedHealthcare
Zerbaxa
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
Targadox
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
Humana
Zerbaxa
- Covered on 0 commercial plans
- PA (0/3) · Step Therapy (0/3) · Qty limit (0/3)
Targadox
- Covered on 0 commercial plans
- PA (1/3) · Step Therapy (2/3) · Qty limit (2/3)
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Zerbaxa.
No savings programs available for Targadox.
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
ZerbaxaView full Zerbaxa profile
TargadoxView full Targadox profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.